CLINICAL TRIALS PROFILE FOR CLENBUTEROL

Clinical Trials for Clenbuterol

Trial ID	Title	Status	Sponsor	Phase	Summary
NCT00585546 ↗	Harefield Recovery Protocol Study for Patients With Refractory Chronic Heart Failure	Terminated	Georgetown University	Phase 1	The purpose of this study is to evaluate whether patients with chronic heart failure not due to coronary artery disease who require use of a left ventricular assist device (LVAD) for refractory heart failure can recover sufficient heart function to allow the pump to be explanted. The study aims to avoid the need for transplantation in these patients by using standard heart failure medications to reduce the size of the left ventricle and then using the investigational drug, clenbuterol, to further improve left ventricular function.
NCT00585546 ↗	Harefield Recovery Protocol Study for Patients With Refractory Chronic Heart Failure	Terminated	Montefiore Medical Center	Phase 1	The purpose of this study is to evaluate whether patients with chronic heart failure not due to coronary artery disease who require use of a left ventricular assist device (LVAD) for refractory heart failure can recover sufficient heart function to allow the pump to be explanted. The study aims to avoid the need for transplantation in these patients by using standard heart failure medications to reduce the size of the left ventricle and then using the investigational drug, clenbuterol, to further improve left ventricular function.
NCT00585546 ↗	Harefield Recovery Protocol Study for Patients With Refractory Chronic Heart Failure	Terminated	Northwestern University	Phase 1	The purpose of this study is to evaluate whether patients with chronic heart failure not due to coronary artery disease who require use of a left ventricular assist device (LVAD) for refractory heart failure can recover sufficient heart function to allow the pump to be explanted. The study aims to avoid the need for transplantation in these patients by using standard heart failure medications to reduce the size of the left ventricle and then using the investigational drug, clenbuterol, to further improve left ventricular function.
NCT00585546 ↗	Harefield Recovery Protocol Study for Patients With Refractory Chronic Heart Failure	Terminated	Ohio State University	Phase 1	The purpose of this study is to evaluate whether patients with chronic heart failure not due to coronary artery disease who require use of a left ventricular assist device (LVAD) for refractory heart failure can recover sufficient heart function to allow the pump to be explanted. The study aims to avoid the need for transplantation in these patients by using standard heart failure medications to reduce the size of the left ventricle and then using the investigational drug, clenbuterol, to further improve left ventricular function.

Clinical Trial Conditions for Clenbuterol

Condition Name

Condition Name
Intervention	Trials
Healthy	2
Asthma	1
Dilated Cardiomyopathy	1
Heart Failure	1

Condition MeSH

Condition MeSH
Intervention	Trials
Glycogen Storage Disease Type II	2
Muscular Atrophy	1
Bulbo-Spinal Atrophy, X-Linked	1
Myocardial Infarction	1

Clinical Trial Locations for Clenbuterol

Trials by Country

Trials by Country
Location	Trials
United States	10
Denmark	3
Netherlands	1
Italy	1

Trials by US State

Trials by US State
Location	Trials
North Carolina	3
Texas	1
Pennsylvania	1
Ohio	1
New York	1

Clinical Trial Progress for Clenbuterol

Clinical Trial Phase

Clinical Trial Phase
Clinical Trial Phase	Trials
Phase 2	5
Phase 1/Phase 2	1
Phase 1	1

Clinical Trial Status

Clinical Trial Status
Clinical Trial Phase	Trials
Completed	4
Recruiting	3
Not yet recruiting	2

Clinical Trial Sponsors for Clenbuterol

Sponsor Name

Sponsor Name
Sponsor	Trials
University of Copenhagen	2
Maastricht University	2
Dwight Koeberl, M.D., Ph.D.	2

Sponsor Type

Sponsor Type
Sponsor	Trials
Other	20
Industry	2